Skip to main content
Top
Published in: Malaria Journal 1/2019

Open Access 01-12-2019 | Malaria | Research

Exploring the heterogeneity of human exposure to malaria vectors in an urban setting, Bouaké, Côte d’Ivoire, using an immuno-epidemiological biomarker

Authors: Dipomin F. Traoré, André B. Sagna, Akré M. Adja, Dounin D. Zoh, Kouassi A. Adou, Kouassi N. Lingué, Issa Coulibaly, N’Cho Bertin Tchiekoi, Serge B. Assi, Anne Poinsignon, Mamadou Dagnogo, Franck Remoue

Published in: Malaria Journal | Issue 1/2019

Login to get access

Abstract

Background

In some African cities, urban malaria is a threat to the health and welfare of city dwellers. To improve the control of the disease, it is critical to identify neighbourhoods where the risk of malaria transmission is the highest. This study aims to evaluate the heterogeneity of malaria transmission risk in one city (Bouaké) in a West African country (Côte d’Ivoire) that presents several levels of urbanization.

Methods

Two cross-sectional studies were conducted in three neighbourhoods (Dar-es-Salam, Kennedy and N’gattakro) in Bouaké during both the rainy and dry seasons. Data on insecticide-treated net (ITN) use and blood samples were collected from children aged between 6 months and 15 years to determine the parasite density and the prevalence of Plasmodium falciparum and the level of IgG against the Anopheles gSG6-P1 salivary peptide, used as the biomarker of Anopheles bite exposure.

Results

The specific IgG levels to the gSG6-P1 salivary peptide in the rainy season were significantly higher compared to the dry season in all neighbourhoods studied (all p < 0.001). Interestingly, these specific IgG levels did not differ between neighbourhoods during the rainy season, whereas significant differences in IgG level were observed in the dry season (p = 0.034). ITN use could be a major factor of variation in the specific IgG level. Nevertheless, no difference in specific IgG levels to the gSG6-P1 salivary peptide was observed between children who declared “always” versus “never” sleeping under an ITN in each neighbourhood. In addition, the prevalence of P. falciparum in the whole population and immune responders was significantly different between neighbourhoods in each season (p < 0.0001).

Conclusion

This study highlights the high risk of malaria exposure in African urban settings and the high heterogeneity of child exposure to the Anopheles vector between neighbourhoods in the same city. The Anopheles gSG6-P1 salivary peptide could be a suitable biomarker to accurately and quantitatively assess the risk of malaria transmission in urban areas.
Appendix
Available only for authorised users
Literature
1.
go back to reference Pages F, Orlandipradines E, Corbel V. Vecteurs du paludisme: biologie, diversité, contrôle et protection individuelle. Med Mal Infect. 2007;37:153–61.CrossRef Pages F, Orlandipradines E, Corbel V. Vecteurs du paludisme: biologie, diversité, contrôle et protection individuelle. Med Mal Infect. 2007;37:153–61.CrossRef
2.
go back to reference Dossou-Yovo J, Doannio JMC, Diarrassouba S, Chauvancy G. Impact d’aménagements de rizières sur la transmission du paludisme dans la ville de Bouaké, Côte d’Ivoire. Bull Soc Path Exot. 1998;91:327–33. Dossou-Yovo J, Doannio JMC, Diarrassouba S, Chauvancy G. Impact d’aménagements de rizières sur la transmission du paludisme dans la ville de Bouaké, Côte d’Ivoire. Bull Soc Path Exot. 1998;91:327–33.
4.
go back to reference Robert V, Macintyre K, Keating J, Trape J-F, Duchemin J-B, Warren M, et al. Malaria transmission in urban sub-Saharan Africa. Am J Trop Med Hyg. 2003;68:169–76.CrossRef Robert V, Macintyre K, Keating J, Trape J-F, Duchemin J-B, Warren M, et al. Malaria transmission in urban sub-Saharan Africa. Am J Trop Med Hyg. 2003;68:169–76.CrossRef
5.
go back to reference Tatem AJ, Gething PW, Smith DL, Hay SI. Urbanization and the global malaria recession. Malar J. 2013;12:133.CrossRef Tatem AJ, Gething PW, Smith DL, Hay SI. Urbanization and the global malaria recession. Malar J. 2013;12:133.CrossRef
6.
go back to reference Hay SI, Guerra CA, Tatem AJ, Atkinson PM, Snow RW. Urbanization, malaria transmission and disease burden in Africa. Nat Rev Microbiol. 2005;3:81–90.CrossRef Hay SI, Guerra CA, Tatem AJ, Atkinson PM, Snow RW. Urbanization, malaria transmission and disease burden in Africa. Nat Rev Microbiol. 2005;3:81–90.CrossRef
7.
go back to reference Donnelly MJ, McCall P, Lengeler C, Bates I, D’Alessandro U, Barnish G, et al. Malaria and urbanization in sub-Saharan Africa. Malar J. 2005;4:12.CrossRef Donnelly MJ, McCall P, Lengeler C, Bates I, D’Alessandro U, Barnish G, et al. Malaria and urbanization in sub-Saharan Africa. Malar J. 2005;4:12.CrossRef
8.
go back to reference Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev. 2004;2:CD000363. Lengeler C. Insecticide-treated bed nets and curtains for preventing malaria. Cochrane Database Syst Rev. 2004;2:CD000363.
9.
go back to reference Maxwell CA, Msuya E, Sudi M, Njunwa KJ, Carneiro IA, Curtis CF. Effect of community-wide use of insecticide-treated nets for 3–4 years on malarial morbidity in Tanzania. Trop Med Int Health. 2002;7:1003–8.CrossRef Maxwell CA, Msuya E, Sudi M, Njunwa KJ, Carneiro IA, Curtis CF. Effect of community-wide use of insecticide-treated nets for 3–4 years on malarial morbidity in Tanzania. Trop Med Int Health. 2002;7:1003–8.CrossRef
10.
go back to reference Mboera LEG. Sampling techniques for adult Afrotropical malaria vectors and their reliability in the estimation of entomological inoculation rate. Tanzan Health Res Bull. 2005;7:117–24.PubMed Mboera LEG. Sampling techniques for adult Afrotropical malaria vectors and their reliability in the estimation of entomological inoculation rate. Tanzan Health Res Bull. 2005;7:117–24.PubMed
11.
go back to reference Badu K, Siangla J, Larbi J, Lawson BW, Afrane Y, Ong’echa J, et al. Variation in exposure to Anopheles gambiae salivary gland peptide (gSG6-P1) across different malaria transmission settings in the western Kenya highlands. Malar J. 2012;11:318.CrossRef Badu K, Siangla J, Larbi J, Lawson BW, Afrane Y, Ong’echa J, et al. Variation in exposure to Anopheles gambiae salivary gland peptide (gSG6-P1) across different malaria transmission settings in the western Kenya highlands. Malar J. 2012;11:318.CrossRef
12.
go back to reference Remoue F, Cornelie S, Ngom A, Boulanger D, Simondon F. Immune responses to arthropod bites during vector-borne diseases. In: Garraud O, editor. Update tropical Immunology. Kerala: Transworld research Network; 2005. p. 377–400. Remoue F, Cornelie S, Ngom A, Boulanger D, Simondon F. Immune responses to arthropod bites during vector-borne diseases. In: Garraud O, editor. Update tropical Immunology. Kerala: Transworld research Network; 2005. p. 377–400.
13.
go back to reference Schwartz BS, Ribeiro JMC, Goldstein MD. Anti-tick antibodies: an epidemiologic tool in Lyme disease research. Am J Epidemiol. 1990;132:58–66.CrossRef Schwartz BS, Ribeiro JMC, Goldstein MD. Anti-tick antibodies: an epidemiologic tool in Lyme disease research. Am J Epidemiol. 1990;132:58–66.CrossRef
14.
go back to reference Poinsignon A, Cornelie S, Mestres-Simon M, Lanfrancotti A, Rossignol M, Boulanger D, et al. Novel peptide marker corresponding to salivary protein gSG6 potentially identifies exposure to Anopheles bites. PLoS ONE. 2008;3:e2472.CrossRef Poinsignon A, Cornelie S, Mestres-Simon M, Lanfrancotti A, Rossignol M, Boulanger D, et al. Novel peptide marker corresponding to salivary protein gSG6 potentially identifies exposure to Anopheles bites. PLoS ONE. 2008;3:e2472.CrossRef
15.
go back to reference Drame PM, Machault V, Diallo A, Cornélie S, Poinsignon A, Lalou R, et al. IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal. Malar J. 2012;11:72.CrossRef Drame PM, Machault V, Diallo A, Cornélie S, Poinsignon A, Lalou R, et al. IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, Sénégal. Malar J. 2012;11:72.CrossRef
16.
go back to reference Sagna AB, Sarr JB, Gaayeb L, Drame PM, Ndiath MO, Senghor S, et al. gSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areas. Parasit Vectors. 2013;6:68.CrossRef Sagna AB, Sarr JB, Gaayeb L, Drame PM, Ndiath MO, Senghor S, et al. gSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areas. Parasit Vectors. 2013;6:68.CrossRef
19.
go back to reference Drame PM, Poinsignon A, Besnard P, Cornelie S, Le Mire J, Toto J-C, et al. Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control. PLoS ONE. 2010;5:e15596.CrossRef Drame PM, Poinsignon A, Besnard P, Cornelie S, Le Mire J, Toto J-C, et al. Human antibody responses to the Anopheles salivary gSG6-P1 peptide: a novel tool for evaluating the efficacy of ITNs in malaria vector control. PLoS ONE. 2010;5:e15596.CrossRef
20.
go back to reference Drame PM, Diallo A, Poinsignon A, Boussari O, Dos Santos S, Machault V, et al. Evaluation of the effectiveness of malaria vector control measures in urban settings of Dakar by a specific Anopheles salivary biomarker. PLoS ONE. 2013;8:e66354.CrossRef Drame PM, Diallo A, Poinsignon A, Boussari O, Dos Santos S, Machault V, et al. Evaluation of the effectiveness of malaria vector control measures in urban settings of Dakar by a specific Anopheles salivary biomarker. PLoS ONE. 2013;8:e66354.CrossRef
21.
go back to reference Traoré DF, Sagna AB, Adja AM, Zoh DD, Lingué KN, Coulibaly I, et al. Evaluation of malaria urban risk using an immuno-epidemiological biomarker of human exposure to Anopheles bites. Am J Trop Med Hyg. 2018;98:1353–9.CrossRef Traoré DF, Sagna AB, Adja AM, Zoh DD, Lingué KN, Coulibaly I, et al. Evaluation of malaria urban risk using an immuno-epidemiological biomarker of human exposure to Anopheles bites. Am J Trop Med Hyg. 2018;98:1353–9.CrossRef
22.
go back to reference Hien S, Angbo K, Dasse S, Yeboah O, N’guessan K, Kouacou A, et al. L’haptoglobine chez les enfants atteints de paludisme grave a Plasmodium falciparum de 0 à 15 ans : relations avec l’âge, la parasitémie et le taux d’hémoglobine. J Appl Biosci. 2014;76:6425.CrossRef Hien S, Angbo K, Dasse S, Yeboah O, N’guessan K, Kouacou A, et al. L’haptoglobine chez les enfants atteints de paludisme grave a Plasmodium falciparum de 0 à 15 ans : relations avec l’âge, la parasitémie et le taux d’hémoglobine. J Appl Biosci. 2014;76:6425.CrossRef
24.
go back to reference Dossou-Yovo J, Doannio JMC, Diarrassouba S. Préférences trophiques des vecteurs du paludisme dans la ville de Bouaké et dans les villages environnants de Côte d’Ivoire. Bull Soc Path Exot. 1998;91:257–8. Dossou-Yovo J, Doannio JMC, Diarrassouba S. Préférences trophiques des vecteurs du paludisme dans la ville de Bouaké et dans les villages environnants de Côte d’Ivoire. Bull Soc Path Exot. 1998;91:257–8.
25.
go back to reference Khaemba BM, Mutani A, Bett MK. Studies of anopheline mosquitoes transmitting malaria in a newly developed highland urban area: a case study of Moi University and its environs. East Afr Med J. 1994;71:159–64.PubMed Khaemba BM, Mutani A, Bett MK. Studies of anopheline mosquitoes transmitting malaria in a newly developed highland urban area: a case study of Moi University and its environs. East Afr Med J. 1994;71:159–64.PubMed
26.
go back to reference Cooke MK, Kahindi SC, Oriango RM, Owaga C, Ayoma E, Mabuka D, et al. ‘A bite before bed’: exposure to malaria vectors outside the times of net use in the highlands of western Kenya. Malar J. 2015;14:259.CrossRef Cooke MK, Kahindi SC, Oriango RM, Owaga C, Ayoma E, Mabuka D, et al. ‘A bite before bed’: exposure to malaria vectors outside the times of net use in the highlands of western Kenya. Malar J. 2015;14:259.CrossRef
27.
go back to reference Vanek MJ, Shoo B, Mtasiwa D, Kiama M, Lindsay SW, Fillinger U, et al. Community-based surveillance of malaria vector larval habitats: a baseline study in urban Dar es Salaam, Tanzania. BMC Public Health. 2006;6:154.CrossRef Vanek MJ, Shoo B, Mtasiwa D, Kiama M, Lindsay SW, Fillinger U, et al. Community-based surveillance of malaria vector larval habitats: a baseline study in urban Dar es Salaam, Tanzania. BMC Public Health. 2006;6:154.CrossRef
28.
go back to reference Rossi P, Belli A, Sabatinelli G. Etude sur la dispersion d’Anopheles gambiae s.l. dans une zone urbaine à Ouagadougou, Burkina Faso. Parassitologia. 1986;28:33–9.PubMed Rossi P, Belli A, Sabatinelli G. Etude sur la dispersion d’Anopheles gambiae s.l. dans une zone urbaine à Ouagadougou, Burkina Faso. Parassitologia. 1986;28:33–9.PubMed
Metadata
Title
Exploring the heterogeneity of human exposure to malaria vectors in an urban setting, Bouaké, Côte d’Ivoire, using an immuno-epidemiological biomarker
Authors
Dipomin F. Traoré
André B. Sagna
Akré M. Adja
Dounin D. Zoh
Kouassi A. Adou
Kouassi N. Lingué
Issa Coulibaly
N’Cho Bertin Tchiekoi
Serge B. Assi
Anne Poinsignon
Mamadou Dagnogo
Franck Remoue
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2019
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-019-2696-z

Other articles of this Issue 1/2019

Malaria Journal 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine